Those used in the UK as effective at preventing symptomatic disease in the majority of people with underlying health conditions as the rest of the population. Category: UncategorisedBy 9 July 2021Leave a commentPost navigationPreviousPrevious post:Guidance: PHE monitoring of the effectiveness of COVID-19 vaccinationNextNext post:COVID-19 vaccines highly effective in clinical risk groups
